Israel-based telehealth technology developer TytoCare, completed an $11m series B round led by health services provider Cambia Health Solutions on Wednesday.
TytoCare markets a range of handheld telehealth devices that patients can use to send relevant data to a medical professional for diagnosis. The data is stored in a secured cloud platform equipped with analytics capabilities.
The company raised $4m in series A capital in March 2014 from OrbiMed Israel Partners and LionBird, before closing out the round in August with funding from healthcare conglomerate Fosun Pharma and pharmacy retail chain Walgreens.
TytoCare has secured a total of $18.5m to date, according to MobiHealth News. It did not disclose the identities of the other series B investors.
Anisha Sood, assistant director of strategic investment at Cambia, said: “The TytoCare platform provides the missing link in telehealth that can increase its adoption, utilisation and clinical quality, improving consumer convenience and ensuring quality care.
“By improving healthcare quality and access, the TytoCare investment helps achieve Cambia’s mission of making the healthcare system person focused and economically sustainable.”